Effects of growth hormone excess on glycated albumin concentrations: Analysis in acromegalic patients

Clinica Chimica Acta

Volumn 440, Issue , 2015, Pages 93-96

  Tamada, Daisuke ^a   Otsuki, Michio ^a   Kitamura, Tetsuhiro ^a   Oshino, Satoru ^a   Saitoh, Youichi ^a   Shimomura, Iichiro ^a   Koga, Masafumi ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kawanishi City Hospital   (Japan)

Author keywords

Acromegaly; Albumin; Glycated albumin; Growth hormone; HbA1c

Indexed keywords

GLYCOSYLATED ALBUMIN; GROWTH HORMONE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED SERUM ALBUMIN; SERUM ALBUMIN;

ACROMEGALY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; IMMUNOASSAY; IMMUNORADIOMETRIC ASSAY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN METABOLISM; AGED; ANALYSIS; BLOOD; BODY MASS; CASE CONTROL STUDY; DIET RESTRICTION;

ACROMEGALY; ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; SERUM ALBUMIN;

EID: 84911482130     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.11.009     Document Type: Article

References (29)

1. Cohen M.P. Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy?. J. Diabet. Complicat. 1988, 2:214-217.
2. Koenig R.J., Peterson C.M., Jones R.L., Saudek C., Lehrman M., Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N. Engl. J. Med. 1976, 295:417-420.
3. Bunn H.F., Gabbay K.H., Gallop P.M. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978, 200:21-27.
4. Jeffcoate S.L. Diabetes control and complications: the role of glycated haemoglobin, 25years on. Diabet. Med. 2004, 21:657-665.
5. Koga M., Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr. J. 2010, 57:751-762.
6. Fukui M., Tanaka M., Hasegawa G., Yoshikawa T., Nakamura N. Association between serum bioavailable testosterone concentration and the ratio of glycated albumin to glycated hemoglobin in men with type 2 diabetes. Diabetes Care 2008, 31:397-401.
7. Koga M., Murai J., Saito H., Matsumoto S., Kasayama S. Effect of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects. Diabetes Res. Clin. Pract. 2009, 84:163-167.
8. Kitamura T., Otsuki M., Tamada D., et al. Glycated albumin is set lower in relation to plasma glucose levels in patients with Cushing's syndrome. Clin. Chim. Acta 2013, 424:164-167.
9. Colao A., Ferone D., Marzullo P., Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr. Rev. 2004, 25:102-152.
10. Rajasoorya C., Holdaway I.M., Wrightson P., Scott D.J., Ibbertson H.K. Determinants of clinical outcome and survival in acromegaly. Clin. Endocrinol. 1994, 41:95-102.
11. Salomon F., Cuneo R.C., Umpleby A.M., Sönksen P.H. Interactions of body fat and muscle mass with substrate concentrations and fasting insulin levels in adults with growth hormone deficiency. Clin. Sci. 1994, 87:201-206.
12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
13. Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol. Int. 2012, 3:8-10.
14. Kouzuma T., Usami T., Yamakoshi M., Takahashi M., Imamura S. An enzymatic method for the measurement of glycated albumin in biological samples. Clin. Chim. Acta 2002, 324:61-71.
15. Isojima T1., Shimatsu A., Yokoya S., et al. Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr. J. 2012, 59:771-780.
16. Rudman D., Feller A.G., Nagraj H.S., et al. Effects of human growth hormone in men over 60years old. N. Engl. J. Med. 1990, 323:1-6.
17. Zachwieja J.J., Bier D.M., Yarasheski K.E. Growth hormone administration in older adults: effects on albumin synthesis. Am. J. Physiol. 1994, 266:840-844.
18. Barle H., Råhlén L., Essén P., et al. Stimulation of human albumin synthesis and gene expression by growth hormone treatment. Clin. Nutr. 2001, 20:59-67.
19. Gore D.C., Honeycutt D., Jahoor F., Wolfe R.R., Herndon D.N. Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch. Surg. 1991, 126:38-43.
20. Takagi K., Tashiro T., Yamamori H., Mashima Y., Nakajima N., Sunaga K. Recombinant human growth hormone and protein metabolism of burned rats and esophagectomized patients. Nutrition 1995, 11:22-26.
21. Haymond M.W., Horber F.F., Mauras N. Human growth hormone but not insulin-like growth factor I positively affects whole-body estimates of protein metabolism. Horm. Res. 1992, 38:73-75.
22. Yarasheski K.E., Zachweija J.J., Angelopoulos T.J., Bier D.M. Short-term growth hormone treatment does not increase muscle protein synthesis in experienced weight lifters. J. Appl. Physiol. 1993, 74:3073-3076.
23. Fryburg D.A., Barrett E.J. Growth hormone acutely stimulates skeletal muscle but not whole-body protein synthesis in humans. Metabolism 1993, 42:1223-1227.
24. Welle S., Thornton C., Statt M., McHenry B. Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60years old. J. Clin. Endocrinol. Metab. 1996, 81:3239-3243.
25. Hamamoto K. Clinical studies on protein and water metabolism by using isotopes. 1. Studies on the metabolism of 131-I-labeled human serum albumin in normal subjects, various endocrine disorders, liver diseases and kidney diseases. Nihon Naibunpi Gakkai Zasshi 1967, 43:118-130. (in Japanese).
26. Kamenický P., Blanchard A., Gauci C., et al. Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria?. J. Clin. Endocrinol. Metab. 2012, 97:2124-2133.
27. Kamenicky P., Blanchard A., Frank M., et al. Body fluid expansion in acromegaly is related to enhanced epithelial sodium channel (ENaC) activity. J. Clin. Endocrinol. Metab. 2011, 96:2127-2135.
28. Kamenicky P., Viengchareun S., Blanchard A., et al. Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly. Endocrinology 2008, 149:3294-3305.
29. Kaji H., Sugimoto T., Nakaoka D., et al. Bone metabolism and body composition in Japanese patients with active acromegaly. Clin. Endocrinol. (Oxf.) 2001, 55:175-181.